
Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Fierce editors discuss the long-awaited merger agreement between Pfizer and Allergan, Martin Shkreli's CEO double duty, and the whimpering conclusion of two hostile takeovers.
The ins and outs of 'Pfizergan,' whatever it is Martin Shkreli's doing and the end of two takeover battles is an episode from FierceBiotech Radio. Fierce editors discuss the long-awaited merger agreement between Pfizer and Allergan, Martin...
This episode belongs to FierceBiotech Radio.
Use the player on this page to stream the episode online.
Published Nov 24, 2015, 28:35 long, audio available.
Fierce editors discuss the long-awaited merger agreement between Pfizer and Allergan, Martin Shkreli's CEO double duty, and the whimpering conclusion of two hostile takeovers.
You can listen to The ins and outs of 'Pfizergan,' whatever it is Martin Shkreli's doing and the end of two takeover battles online on Radio and Podcast. Open the player on this page to stream the available audio.
The ins and outs of 'Pfizergan,' whatever it is Martin Shkreli's doing and the end of two takeover battles is an episode from FierceBiotech Radio.
This episode is 28:35 long.
This episode was published on Nov 24, 2015.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from FierceBiotech Radio when more episodes are available from the podcast feed.
You can listen to The ins and outs of 'Pfizergan,' whatever it is Martin Shkreli's doing and the end of two takeover battles on this page when the episode audio is available from the podcast feed.
The ins and outs of 'Pfizergan,' whatever it is Martin Shkreli's doing and the end of two takeover battles is from FierceBiotech Radio.
Published Nov 24, 2015 and 28:35 long